Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer


<link type=”text/css” rel=”stylesheet” href=”” /><p align=”justify”>CAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic…

A Global Asset Management Seoul Korea Magazine

This post was originally published on this site